Special series: Body dissatisfaction, binge eating, and dieting as interlocking issues in eating disorders research

L. Peterson

DOI: https://doi.org/10.1016/S0005-7894(05)80079-6

1995-12-01

Abstract:

What problem does this paper attempt to address?

Inhibition of GSK-3β Ameliorates Hepatic Ischemia-Reperfusion Injury Through GSK-3β/β-catenin Signaling Pathway in Mice

Yong-Xiang Xia,Ling Lu,Zheng-Shan Wu,Li-Yong Pu,Bei-Cheng Sun,Xue-Hao Wang

DOI: https://doi.org/10.1016/s1499-3872(12)60161-1

IF: 3.355

2012-01-01

Hepatobiliary & Pancreatic Diseases International

Abstract:BACKGROUND: Glycogen synthase kinase (GSK)-3 beta/beta-catenin signaling regulates ischemia-reperfusion (I/R)-induced apoptosis and proliferation, and inhibition of GSK-3 beta has beneficial effects on I/R injury in the heart and the central nervous system. However, the role of this signaling in hepatic I/R injury remains unclear. The present study aimed to investigate the effects and mechanism of GSK-3 beta/beta-catenin signaling in hepatic I/R injury.METHODS: Male C57BL/6 mice (weighing 22-25 g) were pretreated with either SB216763, an inhibitor of GSK-3 beta, or vehicle. These mice were subjected to partial hepatic I/R. Blood was collected for test of alanine aminotransferase (ALT), and liver specimen for assays of phosphorylation at the Ser9 residue of GSK-3 beta, GSK-3 beta activity, axin 2 and the antiapoptotic factors Bcl-2 and survivin, as well as the proliferative factors cyclin D1 and proliferating cell nuclear antigen, and apoptotic index (TUNEL). Real-time PCR, Western blotting and immunohistochemical staining were used.RESULTS: SB216763 increased phospho-GSK-3 beta levels and suppressed GSK-3 beta activity (1880 +/- 229 vs 3280 +/- 272 cpm, P<0.01). ALT peaked at 6 hours after reperfusion. Compared with control, SB216763 decreased ALT after 6 hours of reperfusion (4451 +/- 424 vs 7868 +/- 845 IU/L, P<0.01), and alleviated hepatocyte necrosis and vacuolization. GSK-3 beta inhibition led to the accumulation of beta-catenin in the cytosol (0.40 +/- 0.05 vs 1.31 +/- 0.11, P<0.05) and nucleus (0.62 +/- 0.14 vs 1.73 +/- 0.12, P<0.05), beta-catenin further upregulated the expression of axin 2. Upregulation of GSK-3 beta/beta-catenin signaling increased Bcl-2, survivin and cyclin D1. Serological and histological analyses showed that SB216763 alleviated hepatic I/R-induced injury by reducing apoptosis (1.4 +/- 0.2% vs 3.6 +/- 0.4%, P<0.05) and enhanced liver proliferation (56 +/- 8% vs 19 +/- 4%, P<0.05).CONCLUSION: Inhibition of GSK-3 beta ameliorates hepatic I/R injury through the GSK-3 beta/beta-catenin signaling pathway.
Knock down of PCSK9 can improve myocardial ischemia/reperfusion injury by inhibiting autophagy

Guangwei Huang,Xiyang Lu,Zonggang Duan,Kai Zhang,Xinlin Xiong,Muzhi Lin,Chao Li,Yunquan Li,Lei Xu,Haiyan Zhou,Zhenhua Luo,Wei Li

DOI: https://doi.org/10.21203/rs.3.rs-1610254/v1

2022-01-01

Abstract:Abstract Purpose: To investigate the effect and mechanism of proprotein convertase subtilisin/Kexin type 9 (PCSK9) on myocardial ischemia-reperfusion injury (MIRI) and to provide a reference for clinical prevention and treatment of acute myocardial infarction (AMI).Methods: We established a rat myocardial ischemia/reperfusion (I/R) model and AC16 hypoxia/reoxygenation (H/R) model. A total of 48 adult male Sprague-Dawley rats were randomly assigned into 3 groups (n=16): control（scrambled RNAi was use）, ischemia/reperfusion(I/R), and I/R +SiRNA. In the I/R and I/R +siRNA groups, myocardial ischemia was induced by occlusion of the left anterior descending branch (LAD) of the coronary artery in rats in the I/R group for 0.5 hours reperfused for 3 days. To assess myocardial injury, rats were subjected to the electrocardiogram (ECG), cardiac function, cardiac enzymes, and 2,3,5-triphenyl tetrazolium chloride (TTC) /Evan Blue (EB) staining. Meanwhile, hematoxylin-eosin (HE) staining was used to detect morphological changes of cardiomyocytes in each group, and the level of myocardial fibrosis was quantified by Masson trichrome staining. Differences in expression of autophagy level proteins and Bcl-2/adenovirus E1B 19-kDa interacting protein (BNIP3) signaling-related proteins were determined by protein blotting.Results: PCSK9 mRNA and protein levels were significantly upregulated during cardiomyocyte hypoxia in vitro and in vivo. Immunohistochemistry confirmed that PCSK9 expression was increased in rat hearts 3 days after anterior descending branch ligation. In vitro and in vivo experimental studies revealed that siRNA knockdown of PCSK9 resulted in reduced expression of the autophagic protein Beclin-1, light chain 3 (LC3) compared to control-treated cells and sham-operated groups, at the same time, the presentation of the autophagic pathway BNIP3 was also downregulated. Furthermore, the PCSK9-mediated small interfering RNA (siRNA) group injected into the left ventricular wall significantly improved cardiac function and myocardial infarct size, as well as the expression of mRNA of Recombinant Human Interleukin-1β（IL-1β）and Nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) was significantly downregulated and reduced the inflammatory response compared with the I/R group.Conclusions: In ischemic/hypoxic circumstances, PCSK9 expression was dramatically increased. PCSK9 knockdown alleviated MIRI via the BNIP3-mediated autophagic pathway, and improved myocardial infarct size and cardiac function.
A pr 2 00 4 K-theory of hyperbolic 3-manifolds

I. Nikolaev

Abstract:The subject of present note are relationships between certain class of noncommutative C∗-algebras and geometry of 3-dimensional manifolds which fiber over the circle. We suggest new classification of such manifolds which is based on the K-theory of a C∗-algebra coming from measured foliations and geodesic laminations studied by Thurston et al. In the first part of the paper a bijection between surface bundles with the pseudo-Anosov monodromy and stationary AF C∗-algebras is established. In the second part, we apply the elaborated calculus (rotation numbers, associated number fields) to spell out conjectures on the volume and Dehn surgery invariants of the 3-dimensional manifolds. In particular, our approach implies that the multiplicity of the Gromov-Thurston map M 7→ V ol M is equal to the class number of a real quadratic field associated to the manifold M . This generalizes Bianchi’s formula ([1]) for the imaginary quadratic fields known since 1892.
The Inhibition of Bruton Tyrosine Kinase Alleviates Acute Liver Failure via Downregulation of NLRP3 Inflammasome.

Bingjue Ye,Shiwei Chen,Huiting Guo,Weiyang Zheng,Guohua Lou,Xue Liang,Yanning Liu,Cheng Zhou,Min Zheng

DOI: https://doi.org/10.4049/jimmunol.2001323

2022-01-01

Abstract:There is no effective treatment for acute liver failure (ALF) except for an artificial liver support system (ALSS) and liver transplant. Bruton tyrosine kinase (Btk) plays important immunoregulatory roles in the inflammatory diseases, but its possible function in ALF remains to be characterized. In this study, we detected the phosphorylation level of Btk in ALF mouse liver and analyzed the protective effects of Btk inhibitor on survival rate and liver damage in ALF mouse models. We measured the expression levels of various inflammatory cytokines in the ALF mouse liver and primary human monocytes. In addition, we examined the expression of the NLRP3 inflammasome in mouse models with or without Btk inhibition. Clinically, we observed the dynamic changes of Btk expression in PBMCs of ALSS-treated patients. Our results showed that Btk was upregulated significantly in the experimental ALF mouse models and that Btk inhibition alleviated liver injury and reduced the mortality in these models. The protective effect of Btk inhibitors on ALF mice partially depended on the suppression of NLRP3 inflammasome signaling. Clinical investigations revealed that the dynamic changes of Btk expression in PBMCs could predict the effect of ALSS treatment. Our work shows that Btk inhibition is an effective therapeutic strategy for ALF. Moreover, Btk is a useful indicator to predict the therapeutic effect of ALSS on liver failure, which might have great value in clinical practice.
[Protective effect of glycogen synthase kinase 3β inhibition via peroxisome proliferator-activated receptor alpha activation in mice with acute liver failure].

H B Shi,H L Shi,X Y Zhang,D X Chen,Z P Duan,F Ren

DOI: https://doi.org/10.3760/cma.j.issn.1007-3418.2017.03.010

2017-01-01

Abstract:Objective: To investigate the role of the glycogen synthase kinase 3β (GSK3β) and the peroxisome proliferator-activated receptor alpha (PPARα) signaling pathway in acute liver failure and related mechanisms in a mouse model of acute liver failure induced by D-galactosamine/lipopolysaccharide (D-GalN/LPS). Methods: C57BL/6 mice were given intraperitoneal injection of D-GalN/LPS to establish a mouse model of acute liver failure. SB216763 was used to inhibit the activity of GSK3β and PPARα siRNA was used to inhibit the expression of PPARα. Western blotting was used to measure the expression of PPARα protein. The changes in liver pathology were observed to evaluate liver injury, and the serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were measured to assess liver function. Quantitative real-time PCR was used to measure the mRNA expression of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-12p40 (IL-12p40), and PPARα. A one-way analysis of variance was used for comparison of means between multiple groups; the least significant difference test was used for data with homogeneity of variance, and the Games-Howell method was used for data with heterogeneity of variance. Results: In the mice with liver failure induced by D-GalN/LPS, GSK3β inhibition promoted the mRNA and protein expression of PPARα (F = 13.18 and 301.36, P = 0.00 and 0.00). In the mice with acute liver failure induced by D-GalN/LPS, GSK3β inhibition alleviated liver bleeding, inflammation, and necrosis and reduced the serum levels of ALT (F = 25.16, P = 0.000) and AST (F = 12.96, P = 0.001), as well as the mRNA expression of TNF-α (F = 32.17, P = 0.00), IL-1β (F = 11.57, P = 0.005), and IL-12p40 (F = 14.17, P = 0.015) in liver tissue. The inhibition of PPARα expression reversed the liver-protecting effect of GSK3β inhibition, which manifested as aggravation in liver bleeding, inflammation, and necrosis, increases in the serum levels of ALT (F = 25.16, P = 0.001) and AST (F = 12.96, P = 0.000), and an increase in the mRNA expression of TNF-α (F = 32.17, P = 0.00), IL-1β (F = 11.57, P = 0.024), and IL-12p40 (F = 14.17, P = 0.001) in liver tissue. Conclusion: In mice with acute liver failure induced by D-GalN/LPS, the GSK3β-PPARα-inflammatory factor signaling pathway may play an important role. GSK3β inhibition has a protective effect in mice with acute liver failure possibly by activating the inhibitory inflammatory factor of PPARα.
Ischemic Preconditioning Increases Gsk-3 Beta/Beta-Catenin Levels And Ameliorates Liver Ischemia/Reperfusion Injury In Rats

Yichao Yan,Guangying Li,Xiaofeng Tian,Yingjiang Ye,Zhidong Gao,Jihong Yao,Feng Zhang,Shan Wang

DOI: https://doi.org/10.3892/ijmm.2015.2153

IF: 5.314

2015-01-01

International Journal of Molecular Medicine

Abstract:Ischemic preconditioning (IPC) ameliorates ischemia/reperfusion (I/R) injury in a number of organs, and the glycogen synthase kinase-3 beta (GSK-3 beta)/beta-catenin signaling pathway regulates I/R-induced proliferation and apoptosis in the central nervous system and heart. However, the function of this signaling pathway in IPC during liver I/R remains unclear. Thus, in this study, we aimed to investigte the role of the GSK-3 beta/beta-catenin pathway during I/R and following ischemic preconditioning. For this purpose, 30 Sprague-Dawley rats were randomly divided into the sham-operated, the I/R and the IPC groups (n=10). Following reperfusion, liver pathology, as well as alanine aminotransferase (ALT), aspartate aminotransferase (AST), maleic dialdehyde (MDA) and superoxide dismutase (SOD) levels were assessed. Western blot analysis was performed to quantify the GSK-3 beta, Ser9-phospho-GSK-3 beta (p-GSK-3 beta), cytosolic and nuclear beta-catenin, vascular endothelial growth factor (VEGF), Bcl-2 and survivin levels. In addition, the Bcl-2 and survivin mRNA levels were assessed by RT-qPCR. Compared with the sham-operated group, I/R increased serum ALT, AST and MDA activity and decreased SOD levels, while IPC significantly decreased serum ALT, AST and MDA activity and increased SOD levels, compared with the I/R group. Simultaneously, I/R increased p-GSK-3 beta protein expression, and decreased Bcl-2 and survivin protein and mRNA levels. IPC further increased the protein expression of p-GSK-3 beta, and also increased cytosolic and nuclear beta-catenin and VEGF expression compared with the I/R group; the expression of Bcl-2 and survivin was also increased by IPC, both at the mRNA and protein level. The total GSK-3 beta expression remained unaltered in all the groups. In conclusion, our data demonstrate that IPC exerts protective effects against liver injury induced by I/R and activates the GSK-3 beta/beta-catenin signaling pathway.
Protective Effects of Ginkgo Biloba Dropping Pills Against Liver Ischemia/reperfusion Injury in Mice

Wang Zheng,Zhang Ping,Wang Qingqing,Sheng Xueping,Zhang Jianbing,Lu Xiaoyan,Tianjin University of Traditional Chinese Medicine

DOI: https://doi.org/10.1186/s13020-020-00404-z

IF: 4.546

2020-01-01

Chinese Medicine

Abstract:Abstract Background Liver ischemia/reperfusion (I/R) injury is an inevitable pathological phenomenon in various clinical conditions, such as liver transplantation, resection surgery, or shock, which is the major cause of morbidity and mortality after operation. Ginkgo Biloba Dropping Pill (GBDP) is a unique Chinese Ginkgo Biloba leaf extract preparation that exhibits a variety of beneficial biological activities. The aim of this study is to investigate the protective effects of GBDP on the liver I/R injury both in the in vitro and in vivo. Methods Hypoxia/reoxygenation (H/R) experiments were performed in alpha mouse liver 12 (AML-12) cells and primary hepatocytes, which were pretreated with GBDP (60 or 120 µg/mL) followed by incubation in a hypoxia chamber. Cell viability was detected by 3-(4,5-dimethylthiazol-2-yl)-2.5-diphenyltetrazolium bromide (MTT) assay. Annexin V staining as well as western blot analysis of apoptosis-related proteins was performed to detect the protective effect of GBDP on cell apoptosis induced by H/R injury. C57BL/6 mice were used to establish the liver I/R injury model, and were pretreated with GBDP (100 or 200 mg/kg/day, i.g.) for two weeks. The liver damage was evaluated by detection of plasma levels of alanine transaminase (ALT) and aspartate transaminase (AST), as well as histopathological examinations. Liver inflammation was determined by detecting the secretion of pro-inflammatory cytokines and neutrophil infiltration through enzyme-linked immunosorbent assay (ELISA) and myeloperoxidase (MPO) immunohistochemistry staining. Finally, Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick and labeling (TUNEL) staining and western blot analysis of apoptosis-related proteins were used to investigate the anti-apoptotic effect of GBDP in mice. Results In the in vitro study, GBDP pretreatment improved the cell viability of AML-12 cells in the H/R injury model. Similarly, the same result was found in the primary hepatocytes isolated from C57BL/6 mice. Moreover, GBDP decreased the number of apoptotic cells and reduced the expression of apoptosis-related proteins induced by H/R injury. In the in vivo study, oral administration of GBDP ameliorated liver injury evidenced by a significant decline in the levels of ALT and AST. Furthermore, the result of hematoxylin and eosin (H&E) staining showed that GBDP reduced the size of necrosis area in the liver tissue. In addition, the decreased infiltration of neutrophils and secretion of pro-inflammatory cytokines indicated that GBDP may play an anti-inflammatory effect. More importantly, GBDP reduced TUNEL-positive cells and the expression of apoptosis-related proteins in the liver indicating GBDP has anti-apoptotic effects. Conclusions Our findings elucidated that GBDP has potential effects for protecting against liver I/R injury characterized by its anti-apoptotic, anti-necrotic, and anti-inflammatory properties, which would promisingly make contributions to the exploration of therapeutic strategies in the liver I/R injury.
Activation of Cyclic Adenosine Monophosphate-Dependent Protein Kinase a Signaling Prevents Liver Ischemia/reperfusion Injury in Mice

Hongxiu Ji,Xiu‐Da Shen,Yu Zhang,Feng Gao,Cynthia Huang,Wenguang Chang,Coney Lee,Bibo Ke,Ronald W. Busuttil,Jerzy W. Kupiec‐Weglinski

DOI: https://doi.org/10.1002/lt.23399

2012-01-01

Liver Transplantation

Abstract:Hepatic ischemia/reperfusion injury (IRI) occurs in multiple clinical settings, including liver transplantation. The cyclic adenosine monophosphate (cAMP)–dependent protein kinase A (PKA) pathway inhibits hepatocellular apoptosis and regulates toll-like receptor 4–triggered inflammation responses in vitro. Here we examined the function and therapeutic potential of cAMP-PKA activation in a murine (C57/BL6) model of liver warm ischemia (90 minutes) followed by reperfusion. Liver IRI triggered cAMP-PKA activation, whereas the administration of its specific inhibitor, H89, exacerbated hepatocellular damage. Conversely, forskolin therapy, which activates PKA by elevating cAMP levels, protected livers from IRI; this was evidenced by diminished serum alanine aminotransferase levels and well-preserved tissue architecture. Liver protection due to cAMP-PKA stimulation was accompanied by diminished neutrophil and macrophage infiltration/activation, reduced hepatocyte necrosis/apoptosis, and increased cAMP response element-binding protein (CREB) expression and augmented interleukin-10 (IL-10) expression. The neutralization of IL-10 restored liver damage in otherwise ischemia/reperfusion-resistant, forskolin-treated mice. In vitro, cAMP-PKA activation diminished macrophage tumor necrosis factor α, IL-6, and IL-12 in an IL-10–dependent manner and prevented necrosis/apoptosis in primary mouse hepatocyte cultures. Our novel findings in a mouse model of liver IRI document the importance of cAMP-PKA signaling in hepatic homeostasis and cytoprotection in vivo. The activation of cAMP-PKA signaling differentially regulates local inflammation and prevents hepatocyte death, and this provides a rationale for novel therapeutic approaches to combating liver IRI in transplant recipients. Liver Transpl 18:659–670, 2012. © 2012 AASLD.
Inhibition of GSK3β activity alleviates acute liver failure via suppressing multiple programmed cell death

Danmei Zhang,Chunxia Shi,Qingqi Zhang,Yukun Wang,Jin Guo,Zuojiong Gong

DOI: https://doi.org/10.1186/s12950-023-00350-1

2023-07-15

Journal of Inflammation

Abstract:Acute liver failure (ALF) is one of the most common life-threatening diseases in adults without previous liver disease. Glycogen synthase kinase 3β (GSK3β) is a serine/threonine protein kinase that is widely distributed in the cells. Inhibition of its activity can inhibit cell death and promote autophagy through various pathways, thus providing a protective effect. In this study, we aimed to investigate the effect on ALF after inhibition of GSK3β and its potential mechanisms.

immunology
Pretreatment with Granulocyte Colony‐stimulating Factor Attenuated Renal Ischaemia and Reperfusion Injury Via Activation of PI3/Akt Signal Pathway

Yiwen Li,Jianyong Wu,Zhangfei Shou,Qiang He,Ping Zhang,Fei Han,Hen Li,Jianghua Chen

DOI: https://doi.org/10.1111/j.1440-1797.2008.00928.x

2008-01-01

Nephrology

Abstract:Aim: Granulocyte colony-stimulating factor (G-CSF) has been shown to exert protective effects in various tissues and experimental models of ischaemia-induced injury. However, the mechanism of renoprotective action in ischaemia/reperfusion (I/R) renal injury of G-CSF was unknown.Methods: Male C57BL/6J mice, subjected to renal ischaemia for 45 min, 48 h and 7 days reperfusion, were administered either saline, wortmannin, G-CSF, and G-CSF plus wortmannin 3 days prior to I/R. Saline-treated group served as the control. At 48 h and 7 days of reperfusion, the mice were killed.Results: Significantly, renal dysfunction and morphological injury were identified at 48 h and 7 days after I/R. Wortmannin pretreatment worsened the renal injury significantly. However, G-CSF pretreatment significantly attenuated renal injury, reduced the terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling-positive ratio of renal tubular epithelial cells and inflammation cytokine expression in the kidney. Moreover, G-CSF pretreatment inhibited the expression of Bax and increased the expression of bcl-2 and p-Aktin the kidney. Wortmannin blunted the beneficial effects of G-CSF.Conclusion: The cytoprotective action of G-CSF against I/R injury seems to be associated with its antiapoptotic action mediated by upregulation of p-Akt signal pathway.
The Effects of Therapeutic Hypothermia on the Expression of DKK3 and Myocardial Ischemia-Reperfusion Injury

Hongping Chen,Wei Qian,Ran Zhou,Xueshan Zhang,Tao Chen,Mingyu Su,Yanfeng Ma

DOI: https://doi.org/10.1016/j.intimp.2024.113386

IF: 5.714

2024-01-01

International Immunopharmacology

Abstract:Background: The impact and mechanisms of therapeutic hypothermia (TH) on myocardial ischemia-reperfusion (I/R) injury are still unknown. Methods: Sprague-Dawley (SD) rat model and primary cardiomyocytes were applied in our study. TTC staining evaluated myocardial infarction, while H&E staining assessed myocardial injury. ELISA quantified lactate dehydrogenase (LDH), IL-1 beta, IL-6, and TNF-alpha. Blood serum concentrations of CK, CK-MB, and cTnT were detected using a biochemical assay. TUNEL assay, flow cytometry and western blot were used to detect cell apoptosis. EdU assay was applied to examine cell proliferation. The expression of DKK3 and beta-catenin protein was analyzed using Realtime PCR and Western blot. Results: TH alleviated myocardial infarction size and injury in rat models of I/R, and reduced serum levels of myocardial injury markers and inflammatory factors in animal and cell models. In addition, TH inhibited the increased apoptosis and beta-catenin expression as well as decreased DKK3 expression caused by I/R in I/R cell models, while si-DKK3 reversed the changes brought by TH, and XAV939 inhibited the effects of si-DKK3. Conclusion: TH may reduce myocardial infarction size, myocardial injury, inflammatory response and apoptosis through DKK3/Wnt/beta-catenin pathway, thereby alleviating myocardial I/R injury.
Gsk3β regulates the resolution of liver ischemia/reperfusion injury via MerTK

Hanwen Zhang,Ming Ni,Han Wang,Jing Zhang,Dan Jin,Ronald W. Busuttil,Jerzy W. Kupiec-Weglinski,Wei Li,Xuehao Wang,Yuan Zhai

DOI: https://doi.org/10.1172/jci.insight.151819

IF: 9.4958

2023-01-11

JCI Insight

Abstract:Although glycogen synthase kinase β (Gsk3β) has been shown to regulate tissue inflammation, whether and how it regulates inflammation resolution versus inflammation activation is unclear. In a murine liver, partial warm ischemia/reperfusion injury (IRI) model, we found that Gsk3β inhibitory phosphorylation increased at both the early-activation and late-resolution stages of the disease. Myeloid Gsk3β deficiency not only alleviated liver injuries, it also facilitated the restoration of liver homeostasis. Depletion of Kupffer cells prior to the onset of liver ischemia diminished the differences between the WT and Gsk3β-KO mice in the activation of liver IRI. However, the resolution of liver IRI remained accelerated in Gsk3β-KO mice. In CD11b-DTR mice, Gsk3β-deficient BM-derived macrophages (BMMs) facilitated the resolution of liver IRI as compared with WT cells. Furthermore, Gsk3β deficiency promoted the reparative phenotype differentiation in vivo in liver-infiltrating macrophages and in vitro in BMMs. Gsk3 pharmacological inhibition promoted the resolution of liver IRI in WT, but not myeloid MerTK-deficient, mice. Thus, Gsk3β regulates liver IRI at both activation and resolution stages of the disease. Gsk3 inactivation enhances the proresolving function of liver-infiltrating macrophages in an MerTK-dependent manner.

medicine, research & experimental
Cardioprotection by GSK-3 inhibition: role of enhanced glycogen synthesis and attenuation of calcium overload

Mohamed A Omar,Lianguo Wang,Alexander S Clanachan

DOI: https://doi.org/10.1093/cvr/cvp421

2010-06-01

Abstract:Aims: Glycogen synthase kinase-3 (GSK-3) is a multi-functional kinase that regulates signalling pathways affecting glycogen metabolism, protein synthesis, mitosis, and apoptosis. GSK-3 inhibition limits cardiac ischaemia-reperfusion (IR) injury, but mechanisms are not clearly defined. This study tested the hypothesis that acute GSK-3 inhibition stimulates glycogen synthesis, repartitions glucose away from glycolysis, reduces proton (H+) production from glucose metabolism, and attenuates intracellular Ca2+ (Ca2+(i)) overload. Methods and results: In isolated perfused working rat hearts subjected to global ischaemia and reperfusion, the selective GSK-3 inhibitor, SB-216763 (SB, 3 micromol/L), when added either prior to ischaemia or at the onset of reperfusion, improved recovery of left-ventricular (LV) work. SB increased glycogen synthesis during reperfusion while glycolysis and H+ production were reduced. Rates of glucose and palmitate oxidation were improved by SB. Measurement of Ca2+(i) concentration by rapid acquisition indo-1 fluorescence imaging showed that SB, when added either prior to ischaemia or at the onset of reperfusion, reduced diastolic Ca2+(i) overload during reperfusion. In aerobic hearts depleted of glycogen by substrate-free perfusion to a level similar to that measured at the onset of reperfusion, SB accelerated glycogen synthesis and reduced glycolysis and H+ production independent of changes in LV work. Conclusion: Our study indicates that reduction in H+ production by GSK-3 inhibition is an early and upstream event that lessens Ca2+(i) overload during ischaemia and early reperfusion independent of LV work which enhances the recovery of post-ischaemic LV function and that may ultimately contribute to previously observed reductions in cell death and infarction.
Regulator of G‐protein signaling 14 protects the liver from ischemia–reperfusion injury by suppressing TGF‐β‐activated kinase 1 activation

Jia‐Kai Zhang,Ming‐Jie Ding,Hui Liu,Ji‐Hua Shi,Zhi‐Hui Wang,Pei‐Hao Wen,Yi Zhang,Bing Yan,Dan‐Feng Guo,Xiao‐Dan Zhang,Ruo‐Lin Tao,Zhi‐Ping Yan,Yan Zhang,Zhen Liu,Wen‐Zhi Guo,Shui‐Jun Zhang

DOI: https://doi.org/10.1002/hep.32133

IF: 17.298

2021-12-06

Hepatology

Abstract:Background & AimsHepatic ischemia-reperfusion injury (IRI) is a common complication of hepatectomy and liver transplantation. However, the mechanisms underlying hepatic IRI have not been fully elucidated. The regulator of G-protein signaling 14 (RGS14) is a multifunctional scaffolding protein that integrates G-protein and mitogen-activated protein kinase (MAPK) signaling pathways. However, the role of RGS14 in hepatic IRI remains unclear. Approach & ResultsWe found that RGS14 expression increased in mice subjected to hepatic IR surgery and during hypoxia reoxygenation in hepatocytes. We constructed global RGS14 knockout (RGS14-KO) and hepatocyte-specific RGS14 transgenic (RGS14-TG) mice to establish 70% hepatic IRI models. Histological H&E staining, levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), expression of inflammatory factors, and apoptosis were used to assess liver damage and function in these models. We found that RGS14 deficiency significantly aggravated IR-induced liver injury and activated hepatic inflammatory responses and apoptosis in vivo and in vitro. Conversely, RGS14 overexpression exerted the opposite effect of the RGS14-deficient models. Phosphorylation of transforming growth factor-β-activated kinase 1(TAK1) and its downstream effectors JNK and p38 increased in the liver tissues of RGS14-KO mice, but was repressed in those of RGS14-TG mice. Furthermore, inhibition of TAK1 phosphorylation rescued the effect of RGS14 deficiency on JNK and p38 activation, thus blocking the inflammatory responses and apoptosis. ConclusionsRGS14 plays a protective role in hepatic IR by inhibiting the activation of the TAK1-JNK/p38 signaling pathway. This may be a potential therapeutic strategy for reducing incidences of hepatic IRI in the future.

gastroenterology & hepatology
Glossodynia, iron deficiency anemia, and gastrointestinal malignancy. Report of a case.

F. J. Gallager,D. Baxter,J. Denobile,G. Taybos

DOI: https://doi.org/10.1016/0030-4220(88)90207-1

Abstract:
Sphingosine Kinase 1 Knockout Alleviates Hepatic Ischemia/reperfusion Injury by Attenuating Inflammation and Oxidative Stress in Mice.

Guang-Hui Qiang,Zhong-Xia Wang,An-Lai Ji,Jun-Yi Wu,Yin Cao,Guang Zhang,Yi-Yang Zhang,Chun-Ping Jiang

DOI: https://doi.org/10.1016/j.hbpd.2019.04.001

2019-01-01

Abstract:BACKGROUND:Hepatic ischemia/reperfusion (I/R) injury remains a significant problem in clinical practice. Sphingosine kinase 1 (SphK1) phosphorylates sphingosine to sphingosine-1-phosphate (S1P) which participates in multiple bioactive processes. However, little is known about the role of SphK1 in hepatic I/R injury. This study aimed to investigate the effect of SphK1 knockout on liver I/R injury and to explore underlying mechanisms.METHODS:SphK1 knockout and wild type mice were subjected to 70% partial hepatic I/R. Serum alanine aminotransferase was determined to indicate the degree of liver damage. Hematoxylin-eosin staining and TUNEL assay were used to assess histological changes and hepatocellular apoptosis, respectively. Immunohistochemistry was performed to detect the expression and translocation of phosphorylated p65 and signal transducer and activator of transcription 3 (STAT3). Western blotting was used to determine the expression of S1P receptor 1 (S1PR1), phosphorylated p65 and STAT3. Real-time PCR was used to demonstrate the changes of proinflammatory cytokines. Oxidative stress markers were also determined through biochemical assays.RESULTS:SphK1 knockout significantly ameliorated I/R-induced liver damage, mitigated liver tissue necrosis and apoptosis compared with wild type control. I/R associated inflammation was alleviated in SphK1 knockout mice as demonstrated by attenuated expression of S1PR1 and reduced phosphorylation of nuclear factor kappa B p65 and STAT3. The proinflammatory cytokines interleukin-1β, interleukin-6 and tumor necrosis factor-α were also inhibited by SphK1 genetic deletion. The oxidative stress markers were lower in SphK1 knockout mice after I/R injury than wild type mice.CONCLUSIONS:Knockout of SphK1 significantly alleviated damage after hepatic I/R injury, possibly through inhibiting inflammation and oxidative stress. SphK1 may be a novel and potent target in clinical practice in I/R-related liver injury.
Inhibition of GSK3β and RIP1K Attenuates Glial Scar Formation Induced by Ischemic Stroke via Reduction of Inflammatory Cytokine Production

Jin Liu,Yong-Ming Zhu,Yi Guo,Liang Lin,Zhan-Xiang Wang,Feng Gu,Xin-Yi Dong,Ming Zhou,Yi-Fan Wang,Hui-Ling Zhang

DOI: https://doi.org/10.3389/fphar.2020.00812

2020-06-12

Abstract:In the chronic phase following ischemic stroke, glial scars can prevent axonal regeneration and the intensification of inflammation. The protective effect of inhibition of glycogen synthase kinase-3β (GSK3β) or receptor-interacting protein 1 kinase (RIP1K) on ischemic stroke has been previously reported. The current study examined the effects of RIP1K and GSK3β on ischemic stroke-induced glial scar formation. To investigate this, we used an in vivo model of ischemic stroke based on middle cerebral artery occlusion for 90 min followed by reperfusion for 7 d, and an in vitro model in primary cultured astrocytes involving oxygen and glucose deprivation for 6 h followed by reoxygenation for 24 h. Both in vivo and in vitro, we found that SB216763, a GSK3β inhibitor, and necrostatin-1 (Nec-1), a RIP1K inhibitor, decreased levels of glial scar markers, including glial fibrillary acidic protein (GFAP), neurocan, and phosphacan. SB216763 and Nec-1 also decreased levels of inflammatory related cytokines, including interleukin-6 (IL-6), interleukin-1 β (IL-1β), and tumor necrosis factor-α (TNF-α). However, only Nec-1 increased the level of interleukin-1 receptor antagonist. Concurrent neutralization of TNF-α, IL-1β, and IL-6 with their antibodies provided better reduction in oxygen and glucose deprivation-induced increases in scar markers than obtained with separate use of each antibody. Further investigations showed that SB216763 reduced the levels of necroptosis-related proteins, including RIP1K, p-RIP1K, RIP3K, p-RIP3K, mixed lineage kinase domain-like protein (MLKL), and p-MLKL, while Nec-1 decreased the expression of p-GSK3β. Compared with Nec-1 (10 μM) and SB216763 (1 μM) alone, Nec-1 and SB216763 in combination reduced levels of GFAP, neurocan, and inflammatory-related cytokines. In conclusion, inhibition of GSK3β or RIP1K reduced glial scar formation induced by ischemic stroke. The underlying mechanisms might be at least, partially related to reducing levels of inflammatory-related cytokines and to blocking an interaction between GSK3β- and RIP1K-mediated pathways.
The effect of Ginsenoside Rg1 in hepatic ischemia reperfusion (I/R) injury ameliorates ischemia-reperfusion-induced liver injury by inhibiting apoptosis

Jie Lin,Han-fei Huang,Shi-kun Yang,Jian Duan,Si-ming Qu,Bo Yuan,Zhong Zeng

DOI: https://doi.org/10.1016/j.biopha.2020.110398

2020-09-01

Abstract:Hepatic ischemia reperfusion (I/R) injury (HIRI) HIRI is a complex, multifactorial pathophysiological process and in liver surgery has been known to significantly affect disease prognosis, surgical success rates, and patient survival. Ginsenoside Rgl (Rgl) monomer is one of the main active ingredients of ginseng. Previous studies have demonstrated that Rgl exerts various pharmacological effects through several mechanisms including suppression of apoptosis-related proteins levels, downregulation of inflammatory mediators and as well as antioxidant, which effectively exerts an organ protective effect I/R-induced damage. However, the exact mechanisms of Rg1 on HIRI remain to be elucidated. In the present study, we investigated the protective effect of Rg1 on hepatic ischemia-reperfusion (I/R) injury (HIRI) and explored its underlying molecular mechanism. A rat warm I/R injury model in vivo and an oxygen-glucose deprivation/reperfusion (OGD/R)-treated BRL-3A cell model in vitro were established after pretreating with Rg1(20 mg/kg). The results showed that Rg1 reduced the levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST). TUNEL staining showed that pretreated with Rg1 inhibited the apoptosis rate compared with the I/R group. Moreover, pretreated with Rg1 significantly reduced the expression of Cyt-C, Caspase-9 and Caspase-3 to inhibit the cell apoptosis. Flow cytometry analysis showed the MMP in the I/R group was significantly increased, whereas pretreated with Rg1 effectively stabilized the MMP compared with the I/R group. in vitro, the proliferation of BRL-3A cells was significantly decreased by the OGD/R treatment, while Rg1 effectively reversed this phenomenon. In addition, western blotting showed that the increase of Cyt-C, Caspase-9 and Caspase-3 was inhibited by H2O2. These observations suggest that Rg1 exerts the protective effect by inhibiting the CypD protein-mediated mitochondrial apoptotic pathway.

pharmacology & pharmacy,medicine, research & experimental
Kidney-specific allo- and autoantibodies in the alloantibody response to rat kidney: the use of kidney homogenate as a target for serological analysis.

D. Hart,J. Fabre

1980-04-01

Abstract:LEW anti-DA kidney and DA anti-LEW kidney sera were assayed using an indirect 125I anti-immunoglobulin-binding assay with kidney homogenate as target. This allowed the full spectrum of antibodies to be analysed since the tissue used for immunization was the same as that used as the target in the serological analysis. It was found that around 80% of the LEW anti-DA kidney serum was directed at kidney-specific antigens, approximately half at a kidney-specific alloantigen, and half at a kidney-specific autoantigen. Only a small component, around 20% of the antibodies, was directed at major histocompatibility complex (MHC) antigens. In contrast, the DA anti-LEW kidney serum, which was much weaker, was directed entirely at autoantigens, and was more complex in that at least two autoantigens were involved. None of the DA and LEW kidney autoantibodies reacted with lymphocytes. The potential of this assay system for the study of tissue-specific antibodies, especially autoantibodies in man, is discussed.
PLK2 Inhibited Oxidative Stress and Ameliorated Hepatic Ischemia-Reperfusion Injury Through Phosphorylating GSK3β.

Wenwen Ge,Zhoucheng Wang,Xinyang Zhong,Yutong Chen,Xiao Tang,Shusen Zheng,Xiao Xu,Kai Wang

DOI: https://doi.org/10.1111/jgh.16815

2024-01-01

Journal of Gastroenterology and Hepatology

Abstract:BACKGROUND AND AIM:Hepatic ischemia-reperfusion (I/R) injury is the primary cause of liver dysfunction and liver failure, commonly occurring in liver transplantation, hepatectomy, and hemorrhagic shock. Polo-like kinase 2 (PLK2), a pivotal regulator of centriole duplication, plays a crucial role in cell proliferation and injury repair. However, the function of PLK2 in hepatic I/R remains unclear. METHODS:The effect of PLK2 was investigated in the mouse hepatic I/R model and the hepatocyte hypoxia-reoxygenation (H/R) model. Liver injury was assessed by serum transaminase and hematoxylin and eosin staining. Cell apoptosis was analyzed using TUNEL analysis and immunoblotting. Inflammatory factors were evaluated by reverse transcription-quantitative polymerase chain reaction. Mice or cultured cells during the I/R or H/R were treated by overexpressing PLK2. ROS fluorescence staining was used to assess oxidative stress injury. RESULTS:PLK2 was upregulated after hepatic I/R injury. Overexpressed PLK2 significantly improved liver enzyme levels and alleviated liver histological injury. Moreover, PLK2 decreased hepatocyte apoptosis and inhibited the expression of inflammatory factors in liver. Mechanistically, PLK2 increased the phosphorylation of GSK3β and enhanced expression of the antioxidant enzyme HO-1, leading to less ROS production. Inhibition of the HO-1 aggravated ROS generation and abolished the protective effect of PLK2. CONCLUSION:Overall, these findings revealed that PLK2 enhanced HO-1 expression and reduced oxidative stress damage in hepatic I/R injury, and this protective effect related to GSK3β activity.

Special series: Body dissatisfaction, binge eating, and dieting as interlocking issues in eating disorders research

Inhibition of GSK-3β Ameliorates Hepatic Ischemia-Reperfusion Injury Through GSK-3β/β-catenin Signaling Pathway in Mice

Knock down of PCSK9 can improve myocardial ischemia/reperfusion injury by inhibiting autophagy

A pr 2 00 4 K-theory of hyperbolic 3-manifolds

The Inhibition of Bruton Tyrosine Kinase Alleviates Acute Liver Failure via Downregulation of NLRP3 Inflammasome.

[Protective effect of glycogen synthase kinase 3β inhibition via peroxisome proliferator-activated receptor alpha activation in mice with acute liver failure].

Ischemic Preconditioning Increases Gsk-3 Beta/Beta-Catenin Levels And Ameliorates Liver Ischemia/Reperfusion Injury In Rats

Protective Effects of Ginkgo Biloba Dropping Pills Against Liver Ischemia/reperfusion Injury in Mice

Activation of Cyclic Adenosine Monophosphate-Dependent Protein Kinase a Signaling Prevents Liver Ischemia/reperfusion Injury in Mice

Inhibition of GSK3β activity alleviates acute liver failure via suppressing multiple programmed cell death

Pretreatment with Granulocyte Colony‐stimulating Factor Attenuated Renal Ischaemia and Reperfusion Injury Via Activation of PI3/Akt Signal Pathway

The Effects of Therapeutic Hypothermia on the Expression of DKK3 and Myocardial Ischemia-Reperfusion Injury

Gsk3β regulates the resolution of liver ischemia/reperfusion injury via MerTK

Cardioprotection by GSK-3 inhibition: role of enhanced glycogen synthesis and attenuation of calcium overload

Regulator of G‐protein signaling 14 protects the liver from ischemia–reperfusion injury by suppressing TGF‐β‐activated kinase 1 activation

Glossodynia, iron deficiency anemia, and gastrointestinal malignancy. Report of a case.

Sphingosine Kinase 1 Knockout Alleviates Hepatic Ischemia/reperfusion Injury by Attenuating Inflammation and Oxidative Stress in Mice.

Inhibition of GSK3β and RIP1K Attenuates Glial Scar Formation Induced by Ischemic Stroke via Reduction of Inflammatory Cytokine Production

The effect of Ginsenoside Rg1 in hepatic ischemia reperfusion (I/R) injury ameliorates ischemia-reperfusion-induced liver injury by inhibiting apoptosis

Kidney-specific allo- and autoantibodies in the alloantibody response to rat kidney: the use of kidney homogenate as a target for serological analysis.

PLK2 Inhibited Oxidative Stress and Ameliorated Hepatic Ischemia-Reperfusion Injury Through Phosphorylating GSK3β.